SIA Crosslinker structure
|
Common Name | SIA Crosslinker | ||
---|---|---|---|---|
CAS Number | 39028-27-8 | Molecular Weight | 283.021 | |
Density | 2.1±0.1 g/cm3 | Boiling Point | 315.6±44.0 °C at 760 mmHg | |
Molecular Formula | C6H6INO4 | Melting Point | 148ºC | |
MSDS | Chinese USA | Flash Point | 144.7±28.4 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of SIA CrosslinkerSIA Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
Name | iodoacetic acid n-hydroxysuccinimide ester |
---|---|
Synonym | More Synonyms |
Description | SIA Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
---|---|
Related Catalog | |
Target |
Non-cleavable |
In Vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. |
References |
Density | 2.1±0.1 g/cm3 |
---|---|
Boiling Point | 315.6±44.0 °C at 760 mmHg |
Melting Point | 148ºC |
Molecular Formula | C6H6INO4 |
Molecular Weight | 283.021 |
Flash Point | 144.7±28.4 °C |
Exact Mass | 282.934143 |
PSA | 63.68000 |
LogP | -0.76 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.615 |
Storage condition | −20°C |
Water Solubility | DMF: 50 mg/mL |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2925190090 |
~29% SIA Crosslinker CAS#:39028-27-8 |
Literature: Marco Colas, Maria Pilar; Sánchez Baeza, Francisco José; González Pinacho, Daniel Patent: US2013/273581 A1, 2013 ; Location in patent: Page/Page column 0092; 0111-0112; 0114 ; |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2925190090 |
---|---|
Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
A method for the preparation of protein-protein conjugates of predetermined composition.
J. Immunol. Methods 24 , 321-336, (1978) A novel procedure for the synthesis of well-defined protein-protein conjugates is described using ovalbumin (OA) and IgG as test proteins. This procedure involves the highly selective and rapid reacti... |
|
Conjugation to preactivated proteins using divinylsulfone and iodoacetic acid.
J. Immunol. Methods 181 , 187-200, (1995) Two methods for the preactivation of proteins and conjugation of peptides to proteins under mild conditions are presented. Preactivation of proteins with divinylsulfone (DVS) permits peptide conjugati... |
|
Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.
ACS Nano 7 , 9001-9, (2013) Thrombin is a serine protease and regulator of hemostasis that plays a critical role in the formation of obstructive blood clots, or thrombosis, that is a life-threatening condition associated with nu... |
1-(2-Iodoacetoxy)-2,5-pyrrolidinedione |
N-SucciniMidyl Iodoacetate |
2,5-Pyrrolidinedione, 1-[(2-iodoacetyl)oxy]- |
N-(Iodoacetoxy)succinimide |
1-(2-Iodoacetoxy)pyrrolidine-2,5-dione |
Iodoacetic Acid N-Succinimidyl Ester |
(2,5-dioxopyrrolidin-1-yl) 2-iodoacetate |
N-Succinimidyl iodoacetate(SIA) |